מסגרת עם רקע לכותרת

קריאה ביקורתית – מאמרים לעיון

Absolute risk reduction may depend on the duration of the follow-up

A dirty dozen- twelve p-value misconceptions

If nothing goes wrong - is everything all right

Immortal time bias in Pharmacoepidemiology

Randomized tirals stopped early for benefit

Reflections on meta-analyses involving trials stopped early for benefit: Is there a problem and if so, what is it

Statistics Myth Busters: Dispelling Common Misperceptions Held by Readers of the Biomedical Literature

Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects

The American Statistical Association statement on P-values explained

The Proposal to Lower P Value Thresholds to .005

The “Utility” in Composite Outcome Measures Measuring What Is Important to Patients

Reporting of Systematic Reviews: The Challenge of Genetic Association Studies

XDR-TB in South Africa: Back to TB Sanatoria Perhaps?

Why Most Published Research Findings Are False

תמונה שהיא חסות של - הצטרפות לאיגוד